Community Advocacy & Education to End Stigmatizing HIV/TB Language

Slides:



Advertisements
Similar presentations
Engaging Patients and Other Stakeholders in Clinical Research
Advertisements

David Oyat Abang NAFOPHANU Uganda
CITAM+ Engaging HIV Civil Society in TB ACSM Meeting, Cancun 30 Nov 2009 Carol Nawina Nyirenda National Coordinator Community Initiative for TB, HIV/AIDS.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
WHO operational guidance on community based TB activities and progress to date Haileyesus Getahun Stop TB Department World Health Organisation.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
1. History of creation of STOP TB Partnership, Tajikistan Motivations: The need for joined efforts to fight TB; The voices and the needs of TB patients.
The French National Agency for Research on Aids and Viral Hepatitis – Clinical Research Legislation: A French Experience Ingrid Callies Legal Counsel in.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Health Promotion as a Quality issue
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Ryan White All Grantees Meeting Washington, DC November, 2012 Supporting National HIV/AIDS Strategies: the domestic experience and the AETCs.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
TB/HIV Working Group Working Groups Collaboration to Raise and Enhance Awareness of TB/HIV Colleen Daniels Technical Officer TB/HIV Advocacy & Communications.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Advisory Forum November 28th-29th 2005 HIV, AIDS and Other Sexually Transmitted and Blood Borne Infections Prof Angus Nicoll SNE - HIV & STI Co-ordinator.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
The International AIDS Conference is the largest conference on any global health or development issues in the world. First convened during the peak of.
Effect of Clinical Program Integration on Eliminating Disparities in Access to Care P. Tambe, M. Allen, R. Lewis-Hardy, T. Dupree-Bright, E. Benning, S.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
Firma A. Kisika 1, Duncun Ndimbo 1, Rhoda Kunzugala 2, Richard Mkinga 3, Nolasco Ngoloka 2,, DMOs& DCDOs Iringa 1, Kilolo 2 and Mbinga 3 District Councils.
A global movement to eliminate viral hepatitis by 2030
CLINICAL TRIALS.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Prevention Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network.
The Essentia Institute of Rural Health (EIRH) is
An Overview of the Global Fund and its Architecture
Research Questions Does integration of behavioral health and primary care services, compared to simple co-location, improve patient-centered outcomes in.
Zimbabwe’s shift towards treat all: national country context
Funding stigma reduction for key populations: innovation and actions
MHSC TB, HIV/AIDS and Silicosis Initiatives
Maintaining Visibility 2009
Community Action on Harm Reduction (CAHR) Programme
Addressing violence against women in the Americas: the role of health systems Special Meeting of The Permanent Council On The Subject “Addressing Violence.
Community Advisory Boards on Repeat:
This is an archived document.
NHLBI Perspective Yves Rosenberg, M.D, M.P.H.
Community involvement in scaling up TB/HIV activities
Background to The Conference
Research for all Sharing good practice in research management
TB 2018 Political support for TB from other sectors
Enablers for nationwide expansion of collaborative TB/HIV activities
Envisioning Consumer Participation
Interim TB/HIV Document
Petchsri Sirinirund Advisor to HIV/AIDS Policy and Programme
Retention: What It Means for You
Action Points 6 November 2007 Cape Town, South Africa
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Presentation for Second Meeting of the Global TB/HIV Working Group
Geneva, Switzerland June 2002
South Africa: From ProTest to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Offender Peer Education in the Texas Department of Criminal Justice
Towards Integrated Health in Ontario
Men In Partnership Against AIDS Presentation
4TH TB/HIV WORKING GROUP GLOBAL MEETING
33rd IUATLD World Conference on Lung Health
TB-HIV/AIDS Co-Infection Coordination among Programs
Review of Recommendations for Partner Services
Centers of Excellence for Childhood Obesity
2016 Progress Report.
Prevention Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network.
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

Community Advocacy & Education to End Stigmatizing HIV/TB Language C. Lee1§, R. Campbell2, M. Frick3, R. Siskind4, N. Morar5, B. Seaworth3, J. Schouten2 1Community Research Advisors Group (CRAG), Office of HIV/AIDS Network Coordination2, 3Treatment Action Group (TAG), 4Division of AIDS, NIAID, NIH Worksforce Operations, Communication and Reporting Branch, 5South Africa Medical Research Council, Prevention Research Unit CONCLUSIONS The collaborative advocacy by CRAG and CP adds to the growing body of advocacy led by CABs. This body of work may offer a model for other patient and community groups seeking to combat stigma in clinical research and practice. Efforts to eliminate stigmatizing language may help to reduce the dual stigma of TB/HIV co-infection by improving the terms through which people engage with medical research and public health programs. RESOURCES Stop TB Partnership. Every Word Counts: Suggested Language and Usage for Tuberculosis Communications. 2015. Heartland National TB Center Stop the Stigma Campaign http://www.heartlandntbc.org/stopthestigma/ UNAIDS. HIV Terminology Guidelines. 2015. Zachariah et al. Language in TB services: can we change to patient-centered terminology and stop the paradigm of blaming the patients? IJTLD. 2012;16(6):714–7. Frick et al. End stigmatizing language in TB research and practice. BMJ. 2015;350:h1479. BACKGROUND Many studies have shown that stigma affects the willingness of people with TB and HIV to undergo screening, seek treatment and remain in care. Stigma is multi-dimensional in origin, and one source of stigma is the incriminating terminology used to describe people with TB and TB/HIV. Stigmatizing terms like “suspect” and “defaulter” remain rife in TB/HIV research and practice despite community calls to discontinue these terms. OBJECTIVES To share CP/CRAG global efforts to address the impact of HIV/TB stigma on individuals and communities. To enhance the capacity for advocacy to end the use of stigmatizing terminology in HIV/TB research. To provide community members and researchers with effective strategies to reduce stigma and replace stigmatizing language person-centered terminology. METHODS The Community Research Advisors Group (CRAG), the community advisory board (CAB) to the Tuberculosis Trials Consortium (TBTC), and Community Partners (CP), a group of community representatives working across the 5 National Institutes of Health HIV/AIDS clinical trials networks, formed a collaboration to end the use of stigmatizing TB/HIV terminology. Advocacy activities targeted several types of institutions: (1) Professional societies; (2) Research Networks; (3) Guidelines panels; (4) TB programs. Interventions by CRAG and CP targeted the use of stigmatizing language at multiple stages of the research-to-practice continuum, from research planning and conduct to publication to the translation of research into clinical practice. Advocacy tactics included sign-on letters to professional societies and academic publishers, internal memos addressed to investigators at research networks, community participation in guidelines development, and hospital-based education on stigma. KEY RESULTS Action: CRAG, CP, and other partners write an open letter to the International Union Against TB and Lung Disease (IUATLD) calling for the retirement of stigmatizing and criminalizing language from its conferences and academic journals. Outcome: IUATLD “commits to communicating in a manner that embodies respect for all people affected by TB,” and to include guidance on use of stigmatizing terms in conference and journal submission processes. Action: CRAG sent a memo to TBTC leadership encouraging investigators to eliminate stigmatizing language from proposals, protocols, consent forms, and publications. Sending a formal communication to network leadership was a tactic borrowed from CP. Outcome: The TBTC Publications and Presentations Committee agreed to adopt a standing procedure for replacing stigmatizing terms with patient-centered alternatives. Action: The CRAG and partners urged the Stop TB Partnership to finalize its guidance on non-stigmatizing language in tuberculosis, a document that had remained in early draft form since 2012. Outcome: The Stop TB Partnership finalized and published Every Word Counts: Suggested Language and Usage for Tuberculosis Communications in 2015. Case Study: Heartland National TB Center Stop the Stigma Campaign CRAG member Barbara Seaworth and her team at the Heartland National T Center in San Antonio, Texas led the “Stop the Stigma” Campaign encouraging US TB programmers to stop the use of stigmatizing language. The National TB Controllers Association, the National Society of TB Clinicians, and dozens of state, county, and local health departments and TB programmers pledged to stop using stigmatizing language. The CRAG is an international, community-based advisory body that works to ensure the meaningful participation and engagement of affected communities in research conducted by the U.S. Centers for Disease Control and Prevention’s Tuberculosis Trials Consortium (TBTC). The CP is a Community Partners (CP), a group of community representatives working across the 5 National Institutes of Health HIV/AIDS clinical trials networks Cynthia C Lee CRAG Member ccl2117@gmail.com Mike Frick CRAG Coordinator Mike.Frick@treatmentactiongroup.org Russell Campbell HANC Deputy Director rcampbell@fhcrc.org Barbara Seaworth CRAG Member Barbara.seaworth@dshs.state.tx.us Visit the CP CAB online at https://www.hanc.info/cp Visit the CRAG online at http://crag-tb.tumblr.com PRESENTED AT THE 21ST INTERNATIONAL AIDS CONFERENCE - DURBAN, SOUTH AFRICA